Literature DB >> 6816147

Mild form of Hunter's syndrome: clinical delineation based on 31 cases.

I D Young, P S Harper.   

Abstract

The clinical features are described in 31 cases of the mild form of Hunter's syndrome (mucopolysaccharidosis II) ascertained in the British Isles. The mean age at onset was 4.3 years and at death was 21.7 years. Each patient had a large head and short stature. Umbilical and inguinal herniae were recorded in 95% and 61% of the cases. Evidence of cardiac disease was found in 91%; this was the most common cause of death. All of the patients suffered from frequent upper or lower respiratory tract infection. Middle airways obstruction proved to be a particular hazard. A high incidence of sensorineural deafness and unexplained papilloedema was noted. The importance of regular health care for these individuals is stressed.

Entities:  

Mesh:

Year:  1982        PMID: 6816147      PMCID: PMC1628015          DOI: 10.1136/adc.57.11.828

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Long-term complications in Hunter's syndrome.

Authors:  I D Young; P S Harper
Journal:  Clin Genet       Date:  1979-08       Impact factor: 4.438

2.  The pathology and chemistry of a case of gargoylism.

Authors:  R L BISHTON; R M NORMAN; A TINGEY
Journal:  J Clin Pathol       Date:  1956-11       Impact factor: 3.411

3.  A sex-linked variant of gargoylism.

Authors:  C G MILLMAN; J W WHITTICK
Journal:  J Neurol Neurosurg Psychiatry       Date:  1952-11       Impact factor: 10.154

4.  Gargoylism (dysostosis multiplex): two adult cases with one autopsy.

Authors:  E B SMITH; T C HEMPELMANN; S MOORE; D P BARR
Journal:  Ann Intern Med       Date:  1952-02       Impact factor: 25.391

5.  A Rare Disease in Two Brothers.

Authors:  C Hunter
Journal:  Proc R Soc Med       Date:  1917

6.  Ultrastructural ocular pathology of Hunter's syndrome. Systemic mucopolysaccharidosis type II.

Authors:  T M Topping; K R Kenyon; M F Goldberg; A E Maumenee
Journal:  Arch Ophthalmol       Date:  1971-08

7.  A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms.

Authors:  I D Young; P S Harper; R G Newcombe; I M Archer
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

8.  Clinical and probable genetic heterogeneity within mucopolysaccharidosis. II. Report of a family with a mild form.

Authors:  J R Lichtenstein; G L Bilbrey; V A McKusick
Journal:  Johns Hopkins Med J       Date:  1972-12

9.  Pulmonary disability in the Hurler syndrome (lipochondrodystrophy): a study of two cases.

Authors:  J F MURRAY
Journal:  N Engl J Med       Date:  1959-08-20       Impact factor: 91.245

10.  Multiple peripheral nerve entrapments. An unusual phenotypical variant of the Hunter syndrome (mucopolysaccharidosis II) in a family.

Authors:  G Karpati; S Carpenter; A A Eisen; L S Wolfe; W Feindel
Journal:  Arch Neurol       Date:  1974-12
View more
  34 in total

1.  Retinitis pigmentosa and mucopolysaccharidosis type II: an extremely attenuated phenotype.

Authors:  Y Suzuki; A Aoyama; T Kato; N Shimozawa; T Orii
Journal:  J Inherit Metab Dis       Date:  2009-07-09       Impact factor: 4.982

2.  Sleep-related breathing in children with mucopolysaccharidosis.

Authors:  A Nashed; S Al-Saleh; J Gibbons; I MacLusky; J MacFarlane; A Riekstins; J Clarke; I Narang
Journal:  J Inherit Metab Dis       Date:  2009-06-28       Impact factor: 4.982

3.  Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase.

Authors:  Michel C Tchan; Kerry T Devine; David O Sillence
Journal:  JIMD Rep       Date:  2011-06-22

4.  Successful noninvasive ventilation and enzyme replacement therapy in an adult patient with morbus hunter.

Authors:  M Westhoff; P Litterst
Journal:  JIMD Rep       Date:  2011-12-16

5.  Pituitary function studies in a case of mild Hunter's syndrome (MPS IIB).

Authors:  J Nelson; D Carson
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

6.  Long-term follow-up following bone marrow transplantation for Hunter disease.

Authors:  A Vellodi; E Young; A Cooper; V Lidchi; B Winchester; J E Wraith
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

7.  Sanfilippo syndrome.

Authors:  K S Devi; P Veerraju; B S Rao
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

8.  The Hunter syndrome-functional outcomes for clinical understanding scale (HS-FOCUS) questionnaire: evaluation of measurement properties.

Authors:  Ingela Wiklund; Mireia Raluy-Callado; Donald E Stull; Yvonne Jangelind; David A H Whiteman; Wen-Hung Chen
Journal:  Qual Life Res       Date:  2012-05-19       Impact factor: 4.147

9.  Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).

Authors:  P L Crotty; C B Whitley
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

10.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.